ExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend for ...

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

Johnson & Johnson shares surged Wednesday after the company reported second-quarter results that topped estimates and the company lifted its full-year outlook.

After posting a double beat for Q2 2025, J&J (NYSE:JNJ), the pharma sector’s bellwether for the earnings season, added ~6% on ...

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...

Live Updates Live Coverage Updates appear automatically as they are published. Johnson & Johnson Beats 7:31 am by Eric Bleeker Johnson & Johnson delivered EPS of $2.77, which tops estimates of $2.68.

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

In a testament to its enduring strength and adaptive strategy, Johnson & Johnson (NYSE: JNJ) today announced a strong ...

Johnson & Johnson beat Q2 estimates and raised its 2025 outlook, driven by strong cancer and MedTech sales despite Stelara ...

Johnson & Johnson's stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average's DJIA early gainers. Shares of rival Pfizer Inc. (PFE) were up 0.3% in premarket trades and ...

Dividend stocks are one of the most powerful investing tools to build wealth. The S&P 500 has plenty of magnificent dividend ...